Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global T-Cell Therapy Market Growth (Status and Outlook) 2022-2028

  • LP 4884789
  • 103 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of T-Cell Therapy will have significant change from previous year. According to our (LP Information) latest study, the global T-Cell Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global T-Cell Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States T-Cell Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global T-Cell Therapy market, reaching US$ million by the year 2028. As for the Europe T-Cell Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main T-Cell Therapy players cover Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., and Novartis International AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of T-Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

CAR T Cell Therapy

TCR Therapy

TIL Therapy

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics & Ambulatory Centers

Cancer Research Institutes

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Gilead Sciences, Inc.

Sorrento Therapeutics

Fate Therapeutics Inc.

Novartis International AG

AbbVie Inc.

Adaptimmune Therapeutics PLC

Bluebird Bio

TCR2 Therapeutics, Inc.

Pfizer Inc.

DiaCarta, Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global T-Cell Therapy Market Size 2017-2028

2.1.2 T-Cell Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 T-Cell Therapy Segment by Type

2.2.1 CAR T Cell Therapy

2.2.2 TCR Therapy

2.2.3 TIL Therapy

2.3 T-Cell Therapy Market Size by Type

2.3.1 T-Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global T-Cell Therapy Market Size Market Share by Type (2017-2022)

2.4 T-Cell Therapy Segment by Application

2.4.1 Hospitals

2.4.2 Clinics & Ambulatory Centers

2.4.3 Cancer Research Institutes

2.4.4 Others

2.5 T-Cell Therapy Market Size by Application

2.5.1 T-Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global T-Cell Therapy Market Size Market Share by Application (2017-2022)

3 T-Cell Therapy Market Size by Player

3.1 T-Cell Therapy Market Size Market Share by Players

3.1.1 Global T-Cell Therapy Revenue by Players (2020-2022)

3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2020-2022)

3.2 Global T-Cell Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 T-Cell Therapy by Regions

4.1 T-Cell Therapy Market Size by Regions (2017-2022)

4.2 Americas T-Cell Therapy Market Size Growth (2017-2022)

4.3 APAC T-Cell Therapy Market Size Growth (2017-2022)

4.4 Europe T-Cell Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa T-Cell Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas T-Cell Therapy Market Size by Country (2017-2022)

5.2 Americas T-Cell Therapy Market Size by Type (2017-2022)

5.3 Americas T-Cell Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC T-Cell Therapy Market Size by Region (2017-2022)

6.2 APAC T-Cell Therapy Market Size by Type (2017-2022)

6.3 APAC T-Cell Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe T-Cell Therapy by Country (2017-2022)

7.2 Europe T-Cell Therapy Market Size by Type (2017-2022)

7.3 Europe T-Cell Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa T-Cell Therapy by Region (2017-2022)

8.2 Middle East & Africa T-Cell Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa T-Cell Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global T-Cell Therapy Market Forecast

10.1 Global T-Cell Therapy Forecast by Regions (2023-2028)

10.1.1 Global T-Cell Therapy Forecast by Regions (2023-2028)

10.1.2 Americas T-Cell Therapy Forecast

10.1.3 APAC T-Cell Therapy Forecast

10.1.4 Europe T-Cell Therapy Forecast

10.1.5 Middle East & Africa T-Cell Therapy Forecast

10.2 Americas T-Cell Therapy Forecast by Country (2023-2028)

10.2.1 United States T-Cell Therapy Market Forecast

10.2.2 Canada T-Cell Therapy Market Forecast

10.2.3 Mexico T-Cell Therapy Market Forecast

10.2.4 Brazil T-Cell Therapy Market Forecast

10.3 APAC T-Cell Therapy Forecast by Region (2023-2028)

10.3.1 China T-Cell Therapy Market Forecast

10.3.2 Japan T-Cell Therapy Market Forecast

10.3.3 Korea T-Cell Therapy Market Forecast

10.3.4 Southeast Asia T-Cell Therapy Market Forecast

10.3.5 India T-Cell Therapy Market Forecast

10.3.6 Australia T-Cell Therapy Market Forecast

10.4 Europe T-Cell Therapy Forecast by Country (2023-2028)

10.4.1 Germany T-Cell Therapy Market Forecast

10.4.2 France T-Cell Therapy Market Forecast

10.4.3 UK T-Cell Therapy Market Forecast

10.4.4 Italy T-Cell Therapy Market Forecast

10.4.5 Russia T-Cell Therapy Market Forecast

10.5 Middle East & Africa T-Cell Therapy Forecast by Region (2023-2028)

10.5.1 Egypt T-Cell Therapy Market Forecast

10.5.2 South Africa T-Cell Therapy Market Forecast

10.5.3 Israel T-Cell Therapy Market Forecast

10.5.4 Turkey T-Cell Therapy Market Forecast

10.5.5 GCC Countries T-Cell Therapy Market Forecast

10.6 Global T-Cell Therapy Forecast by Type (2023-2028)

10.7 Global T-Cell Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Gilead Sciences, Inc.

11.1.1 Gilead Sciences, Inc. Company Information

11.1.2 Gilead Sciences, Inc. T-Cell Therapy Product Offered

11.1.3 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Gilead Sciences, Inc. Main Business Overview

11.1.5 Gilead Sciences, Inc. Latest Developments

11.2 Sorrento Therapeutics

11.2.1 Sorrento Therapeutics Company Information

11.2.2 Sorrento Therapeutics T-Cell Therapy Product Offered

11.2.3 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sorrento Therapeutics Main Business Overview

11.2.5 Sorrento Therapeutics Latest Developments

11.3 Fate Therapeutics Inc.

11.3.1 Fate Therapeutics Inc. Company Information

11.3.2 Fate Therapeutics Inc. T-Cell Therapy Product Offered

11.3.3 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Fate Therapeutics Inc. Main Business Overview

11.3.5 Fate Therapeutics Inc. Latest Developments

11.4 Novartis International AG

11.4.1 Novartis International AG Company Information

11.4.2 Novartis International AG T-Cell Therapy Product Offered

11.4.3 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis International AG Main Business Overview

11.4.5 Novartis International AG Latest Developments

11.5 AbbVie Inc.

11.5.1 AbbVie Inc. Company Information

11.5.2 AbbVie Inc. T-Cell Therapy Product Offered

11.5.3 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 AbbVie Inc. Main Business Overview

11.5.5 AbbVie Inc. Latest Developments

11.6 Adaptimmune Therapeutics PLC

11.6.1 Adaptimmune Therapeutics PLC Company Information

11.6.2 Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered

11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Adaptimmune Therapeutics PLC Main Business Overview

11.6.5 Adaptimmune Therapeutics PLC Latest Developments

11.7 Bluebird Bio

11.7.1 Bluebird Bio Company Information

11.7.2 Bluebird Bio T-Cell Therapy Product Offered

11.7.3 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bluebird Bio Main Business Overview

11.7.5 Bluebird Bio Latest Developments

11.8 TCR2 Therapeutics, Inc.

11.8.1 TCR2 Therapeutics, Inc. Company Information

11.8.2 TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered

11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 TCR2 Therapeutics, Inc. Main Business Overview

11.8.5 TCR2 Therapeutics, Inc. Latest Developments

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Information

11.9.2 Pfizer Inc. T-Cell Therapy Product Offered

11.9.3 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pfizer Inc. Main Business Overview

11.9.5 Pfizer Inc. Latest Developments

11.10 DiaCarta, Inc.

11.10.1 DiaCarta, Inc. Company Information

11.10.2 DiaCarta, Inc. T-Cell Therapy Product Offered

11.10.3 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 DiaCarta, Inc. Main Business Overview

11.10.5 DiaCarta, Inc. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. T-Cell Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CAR T Cell Therapy

Table 3. Major Players of TCR Therapy

Table 4. Major Players of TIL Therapy

Table 5. T-Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global T-Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global T-Cell Therapy Market Size Market Share by Type (2017-2022)

Table 8. T-Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global T-Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global T-Cell Therapy Market Size Market Share by Application (2017-2022)

Table 11. Global T-Cell Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global T-Cell Therapy Revenue Market Share by Player (2020-2022)

Table 13. T-Cell Therapy Key Players Head office and Products Offered

Table 14. T-Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global T-Cell Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global T-Cell Therapy Market Size Market Share by Regions (2017-2022)

Table 19. Americas T-Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas T-Cell Therapy Market Size Market Share by Country (2017-2022)

Table 21. Americas T-Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas T-Cell Therapy Market Size Market Share by Type (2017-2022)

Table 23. Americas T-Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas T-Cell Therapy Market Size Market Share by Application (2017-2022)

Table 25. APAC T-Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC T-Cell Therapy Market Size Market Share by Region (2017-2022)

Table 27. APAC T-Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC T-Cell Therapy Market Size Market Share by Type (2017-2022)

Table 29. APAC T-Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC T-Cell Therapy Market Size Market Share by Application (2017-2022)

Table 31. Europe T-Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe T-Cell Therapy Market Size Market Share by Country (2017-2022)

Table 33. Europe T-Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe T-Cell Therapy Market Size Market Share by Type (2017-2022)

Table 35. Europe T-Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe T-Cell Therapy Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa T-Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa T-Cell Therapy Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa T-Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa T-Cell Therapy Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa T-Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa T-Cell Therapy Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of T-Cell Therapy

Table 44. Key Market Challenges & Risks of T-Cell Therapy

Table 45. Key Industry Trends of T-Cell Therapy

Table 46. Global T-Cell Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global T-Cell Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global T-Cell Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global T-Cell Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global T-Cell Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global T-Cell Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 52. Gilead Sciences, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 53. Gilead Sciences, Inc. T-Cell Therapy Product Offered

Table 54. Gilead Sciences, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Gilead Sciences, Inc. Main Business

Table 56. Gilead Sciences, Inc. Latest Developments

Table 57. Sorrento Therapeutics Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 58. Sorrento Therapeutics T-Cell Therapy Product Offered

Table 59. Sorrento Therapeutics Main Business

Table 60. Sorrento Therapeutics T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Sorrento Therapeutics Latest Developments

Table 62. Fate Therapeutics Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 63. Fate Therapeutics Inc. T-Cell Therapy Product Offered

Table 64. Fate Therapeutics Inc. Main Business

Table 65. Fate Therapeutics Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Fate Therapeutics Inc. Latest Developments

Table 67. Novartis International AG Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 68. Novartis International AG T-Cell Therapy Product Offered

Table 69. Novartis International AG Main Business

Table 70. Novartis International AG T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Novartis International AG Latest Developments

Table 72. AbbVie Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 73. AbbVie Inc. T-Cell Therapy Product Offered

Table 74. AbbVie Inc. Main Business

Table 75. AbbVie Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. AbbVie Inc. Latest Developments

Table 77. Adaptimmune Therapeutics PLC Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 78. Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered

Table 79. Adaptimmune Therapeutics PLC Main Business

Table 80. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Adaptimmune Therapeutics PLC Latest Developments

Table 82. Bluebird Bio Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 83. Bluebird Bio T-Cell Therapy Product Offered

Table 84. Bluebird Bio Main Business

Table 85. Bluebird Bio T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Bluebird Bio Latest Developments

Table 87. TCR2 Therapeutics, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 88. TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered

Table 89. TCR2 Therapeutics, Inc. Main Business

Table 90. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. TCR2 Therapeutics, Inc. Latest Developments

Table 92. Pfizer Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 93. Pfizer Inc. T-Cell Therapy Product Offered

Table 94. Pfizer Inc. Main Business

Table 95. Pfizer Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Pfizer Inc. Latest Developments

Table 97. DiaCarta, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors

Table 98. DiaCarta, Inc. T-Cell Therapy Product Offered

Table 99. DiaCarta, Inc. Main Business

Table 100. DiaCarta, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. DiaCarta, Inc. Latest Developments

List of Figures

Figure 1. T-Cell Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global T-Cell Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global T-Cell Therapy Market Size Market Share by Type in 2021

Figure 7. T-Cell Therapy in Hospitals

Figure 8. Global T-Cell Therapy Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. T-Cell Therapy in Clinics & Ambulatory Centers

Figure 10. Global T-Cell Therapy Market: Clinics & Ambulatory Centers (2017-2022) & ($ Millions)

Figure 11. T-Cell Therapy in Cancer Research Institutes

Figure 12. Global T-Cell Therapy Market: Cancer Research Institutes (2017-2022) & ($ Millions)

Figure 13. T-Cell Therapy in Others

Figure 14. Global T-Cell Therapy Market: Others (2017-2022) & ($ Millions)

Figure 15. Global T-Cell Therapy Market Size Market Share by Application in 2021

Figure 16. Global T-Cell Therapy Revenue Market Share by Player in 2021

Figure 17. Global T-Cell Therapy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas T-Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 19. APAC T-Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Europe T-Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa T-Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 22. Americas T-Cell Therapy Value Market Share by Country in 2021

Figure 23. Americas T-Cell Therapy Consumption Market Share by Type in 2021

Figure 24. Americas T-Cell Therapy Market Size Market Share by Application in 2021

Figure 25. United States T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC T-Cell Therapy Market Size Market Share by Region in 2021

Figure 30. APAC T-Cell Therapy Market Size Market Share by Application in 2021

Figure 31. China T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe T-Cell Therapy Market Size Market Share by Country in 2021

Figure 38. Europe T-Cell Therapy Market Size Market Share by Type in 2021

Figure 39. Europe T-Cell Therapy Market Size Market Share by Application in 2021

Figure 40. Germany T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa T-Cell Therapy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa T-Cell Therapy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa T-Cell Therapy Market Size Market Share by Application in 2021

Figure 48. Egypt T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country T-Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 54. APAC T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 55. Europe T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 57. United States T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Canada T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 61. China T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Japan T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Korea T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 65. India T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Australia T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Germany T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 68. France T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 69. UK T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Italy T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Russia T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Spain T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 75. Israel T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey T-Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries T-Cell Therapy Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450